Food News and Research

RSS

FDA to highlight benefits and risks of hormone therapy for menopausal symptoms

The Food and Drug Administration (FDA) is implementing a nationwide information campaign to raise awareness about the resources available to address questions related to the benefits and risks of hormone therapy for menopausal symptoms.

29 Sep 2004

Dust collected from the homes of children with persistent allergic symptoms had higher levels of common chemical additives

Dust collected from the homes of children with persistent allergic symptoms had higher levels of certain phthalates, a class of common chemical additives, in it than dust found in homes of children without symptoms, according to a study published in the October 2004 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).

29 Sep 2004

Millions of Asian Americans and Pacific Islanders at increased risk for type 2 diabetes

About 40 percent of adults ages 40 to 74 - or 41 million people - have pre-diabetes, a condition that raises a person’s risk for developing type 2 diabetes, heart disease, and stroke.

29 Sep 2004

Biomira and Merck announce fast track status for liposome vaccine

Biomira and Merck KGaA have announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track status to the investigation of BLP25 Liposome Vaccine (L-BLP25) for its proposed use in the treatment of non-small cell lung cancer (NSCLC).

29 Sep 2004

Scientists develop rapid-fire tests for botulinum toxin

Scientists at the University of Wisconsin-Madison have developed a pair of rapid-fire tests for botulinum toxin, a feat that could underpin new technologies to thwart bioterrorism and spur the development of agents to blunt the toxic action of the world's most poisonous substance.

29 Sep 2004

We could soon be curing our athlete’s foot with alfalfa

We could be soon be curing our athlete’s foot with a common type of cattle feed, according to research reported today at the British Pharmaceutical Conference.

29 Sep 2004

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Scientists at the University of Aberdeen have been awarded £196,166 to help fund pioneering research, which is exploring a method of combating certain conditions and diseases such as asthma and multiple sclerosis.

29 Sep 2004

Shoppers misled by minced meat fat content labelling

Britain's Food Standards Agency has found that shoppers are often being misled by minced meat labels which claim that the product contains less fat than it actually does.

28 Sep 2004

BMA calls for total ban of smoking in enclosed public places

In his speech today, at the BMA's fringe meeting at the Labour Party Conference in Brighton, BMA Chairman, Mr James Johnson, called upon the Health Secretary, John Reid, to introduce a total ban of smoking in enclosed public places and emphasised that a ban must include pubs and restaurants.

28 Sep 2004

Microfluidics help lab-on-a-chip development skyrocket

Lab-on-a-chip (LOC) development has skyrocketed in the last couple of years due to constant efforts in harnessing microfluidics and µTAS to improve the LOC design and function. The distinct advantages that they bestow on applications are pushing the commercial potential of LOCs.

28 Sep 2004

Eating too much in childhood predicts development of bulimia nervosa in adulthood

154 sister pairs were compared. Mothers were sent questionnaires to report on their daughters' childhood feeding experiences. Lifetime diagnosis of eating disorder was obtained with a semi-structured interview.

27 Sep 2004

Don't choose tomatoes based on colour

If a tomato is bright red, round and reasonably large, it should be a tasty tomato, right? Wrong!

27 Sep 2004

High calcium intake and vigorous exercise is the key to optimal increases in bone density

Prepubescence is a critical time for building bone mass in children. Strong bones are important for obvious reasons in growth and development. It is widely accepted that calcium intake and physical activity are two ways one can positively impact bone density.

27 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

Drug companies and FDA crack down on Canadian drug importation to protect profits

With an election on the horizon, and Canadian pharmacies proving to be as safe as U.S. counterparts, the Food and Drug Administration and big pharma are increasing efforts to prevent Canadian drug importation.

26 Sep 2004

Drug shortages are having major negative effects on patient care and hospital costs

A study to be published in the October 1, 2004, issue of the American Journal of Health-System Pharmacy finds that ongoing drug shortages are having far-ranging, negative effects on patient care and hospital costs.

26 Sep 2004

Palladone approved for pain relief

The Food and Drug Administration (FDA) has approved Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous around-the-clock opioid pain relief for an extended period of time.

26 Sep 2004

Boldly colored tableware is a mealtime aid to those with severe Alzheimer's disease

According to new visual perception research from a team at Boston University, the use of boldly colored tableware is a mealtime aid to those with severe AD, helping individuals overcome a diminished sensitivity to visual contrast, a condition often found among people with advanced AD.

26 Sep 2004

Pneumonia could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin

Pneumonia - one of the world’s deadliest diseases for young children in developing countries - could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin, with implications for better health outcomes and reduced costs

23 Sep 2004

Food News and Research

FDA to highlight benefits and risks of hormone therapy for menopausal symptoms

Dust collected from the homes of children with persistent allergic symptoms had higher levels of common chemical additives

Millions of Asian Americans and Pacific Islanders at increased risk for type 2 diabetes

Biomira and Merck announce fast track status for liposome vaccine

Scientists develop rapid-fire tests for botulinum toxin

We could soon be curing our athlete’s foot with alfalfa

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Shoppers misled by minced meat fat content labelling

BMA calls for total ban of smoking in enclosed public places

Microfluidics help lab-on-a-chip development skyrocket

Eating too much in childhood predicts development of bulimia nervosa in adulthood

Don't choose tomatoes based on colour

High calcium intake and vigorous exercise is the key to optimal increases in bone density

New drug application to market ramelteon for insomnia

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Drug companies and FDA crack down on Canadian drug importation to protect profits

Drug shortages are having major negative effects on patient care and hospital costs

Palladone approved for pain relief

Boldly colored tableware is a mealtime aid to those with severe Alzheimer's disease

Pneumonia could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News